English 
Chinese 
Hong Kong Weike Biotechnology Company Limited was awarded「年度最傑出生物技術產品」of the HKCT Business Awards 2023 held by Hong Kong Economic Times. Our CEO, James Chan was invited to receive the recognition award on the Award Presentation Ceremony.
In the past year, Hong Kong Weike has been providing comprehensive and professional consultancy services to clients through our state-of-the-art biotechnological products. This recognition will certainly drive us to continue our hard work in the coming new year!
Other news
Asia’s Most Valuable Brand Awards 2024
Hong Kong Weike Biotechnology Company Limited was awarded “Most Trusted Biotechnology Solutions Of The Year” of Asia’s
Sep
Scientific Annual Report of CELLBANKERs (2023)
・ The number of citations in 2023 was 266 and reached record high. ・The number of
May
HKCT Business Awards 2023
Hong Kong Weike Biotechnology Company Limited was awarded「年度最傑出生物技術產品」of the HKCT Business Awards 2023 held by
Sep
Global Cell Freezing Media for Cell Therapy Professional Survey Report
A report titled, “Global Cell Freezing Media for Cell Therapy Professional Survey Report 2022, Forecast
Apr
CELLBANKER’s Scientific Annual Report (2021)
ZENOAQ has issued publications on research of cell cryopreserved regularly. Here is the summary for
Feb